STOCK TITAN

Augmedix, Inc. - AUGX STOCK NEWS

Welcome to our dedicated page for Augmedix news (Ticker: AUGX), a resource for investors and traders seeking the latest updates and insights on Augmedix stock.

Augmedix Inc (AUGX) is a leading telemedicine charting service for healthcare providers, streamlining EHR documentation and saving providers 17 hours weekly. By leveraging wearable technology, Augmedix connects clinics with its charting service, allowing providers to focus on patient care.

Augmedix caters to the ambulatory, clinical, and hospital segments of the U.S. patient care services market, offering products that address medical note documentation needs. Its innovative solutions extract data from natural clinician-patient conversations, converting it in real-time to medical notes that seamlessly integrate with electronic health records (EHR).

The company generates revenue through service fees charged to customers for subscribing to its remote medical documentation and clinical support products. Augmedix is dedicated to empowering clinicians, enhancing care delivery, and improving operational outcomes.

Rhea-AI Summary
Augmedix expands medical documentation products to behavioral healthcare field
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.4%
Tags
none
-
Rhea-AI Summary
Augmedix earns HITRUST certification for information security, validating commitment to strong cybersecurity and regulations. This achievement places Augmedix in an elite group of organizations worldwide. Augmedix takes compliance and information risk management seriously, ensuring patient information is protected. Customers can trust Augmedix to address industry threats and maintain compliance, data protection, and privacy requirements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.23%
Tags
none
-
Rhea-AI Summary
Augmedix announces participation in investor conferences during September 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.91%
Tags
conferences
Rhea-AI Summary
Augmedix reports strong Q2 2023 financial results with revenue of $10.8 million, a 47% YoY increase. Dollar-based Net Revenue Retention at 148%. Gross margin increased to 47.0%. EBITDA losses declined to $4.2 million. Cash, cash equivalents, and restricted cash were $25.3 million as of June 30, 2023. Revenue guidance for 2023 is at least $43.5 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.66%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.14%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
Rhea-AI Summary

Augmedix (Nasdaq: AUGX) has announced a partnership with HCA Healthcare to enhance ambient medical documentation in acute care settings. This collaboration aims to develop AI-driven documentation products that enable real-time conversion of clinician-patient conversations into medical notes, thereby streamlining workflows for healthcare professionals. HCA Healthcare is currently piloting Augmedix's technology in emergency departments and plans to expand this pilot program. The partnership includes a financial investment from HCA Healthcare to accelerate Augmedix's R&D efforts. Both companies envision this technology improving patient care by allowing clinicians to focus more on patients and less on administrative tasks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
88.89%
Tags
partnership

FAQ

What is the current stock price of Augmedix (AUGX)?

The current stock price of Augmedix (AUGX) is $2.35 as of October 2, 2024.

What is the market cap of Augmedix (AUGX)?

The market cap of Augmedix (AUGX) is approximately 116.2M.

What does Augmedix (AUGX) offer to healthcare providers?

Augmedix provides a telemedicine charting service that streamlines EHR documentation, saving providers significant time.

How does Augmedix help healthcare organizations?

Augmedix's products extract data from clinician-patient conversations, convert it into medical notes, and seamlessly transfer them to EHR systems.

How does Augmedix generate revenue?

The company charges service fees to customers for subscribing to its remote medical documentation and clinical support products.

What segments of the U.S. patient care services market does Augmedix operate in?

Augmedix caters to the ambulatory, clinical, and hospital segments of the U.S. patient care services market.

What is the core focus of Augmedix's products?

Augmedix's products focus on addressing medical note documentation needs for healthcare organizations, from large hospitals to individual practitioners.

Augmedix, Inc.

Nasdaq:AUGX

AUGX Rankings

AUGX Stock Data

116.16M
48.69M
1.5%
84.78%
2.16%
Health Information Services
Services-business Services, Nec
Link
United States of America
SAN FRANCISCO